Low-dose versus standard-dose azithromycin for treatment of yaws
| Authors | |
|---|---|
| Year of publication | 2018 |
| Type | Article in Periodical |
| Magazine / Source | LANCET GLOBAL HEALTH |
| MU Faculty or unit | |
| Citation | |
| Web | http://dx.doi.org/10.1016/S2214-109X(18)30067-6 |
| Doi | http://dx.doi.org/10.1016/S2214-109X(18)30067-6 |
| Keywords | azithromycin |
| Description | In their Article in The Lancet Global Health, Michael Marks and colleagues1 compare the efficacy of low-dose azithromycin (20 mg/kg) versus standard-dose azithromycin (30 mg/kg) for the treatment of yaws. The lower dose of azithromycin is commonly used for trachoma elimination and, since yaws and trachoma are co-endemic in several regions,2 mass treatment with low-dose azithromycin could also aid yaws eradication. If a low-dose azithromycin treatment is as effective against yaws as standard-dose azithromycin, yaws eradication programmes can expect a considerable cost saving. |